Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 25 February 2000:
Vol. 287. no. 5457, pp. 1425 - 1427
DOI: 10.1126/science.287.5457.1425
Prev | Table of Contents | Next

Viewpoint

Europe Confronts the Embryonic Stem Cell Research Challenge

Noëlle Lenoir

Europe's historic plurality and the lack of a commonly accepted definition of the moral status of the embryo have led to varying regulation in European countries. Council of Europe and European Union legislation, based on fundamental ethical principles, does exist for specific issues, such as prohibition against producing embryos solely for research. Such principles have recently been elucidated by the European Group on Ethics in Science and New Technologies. Newly emerging research techniques are beginning to cause reconsideration of the regulation of embryo research in Europe.

The author is at the Conseil Constitutionnel, 2 rue de Montpensier, Paris 75001, France. E-mail: noelle.lenoir{at}wanadoo.fr

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryos.
J-E S Hansen (2002)
J. Med. Ethics 28, 86-88
   Abstract »    Full Text »    PDF »
{beta} Cell Replacement for the Treatment of Diabetes.
J. OBERHOLZER, C. TOSO, F. RIS, P. BUCHER, F. TRIPONEZ, A. DEMIRAG, J. LOU, and P. MOREL (2001)
Ann. N.Y. Acad. Sci. 944, 373-387
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)